Transdiagnostic therapy based on the research domain criteria framework for non-suicidal self-injury
- Conditions
- onsuicidal self-injury.
- Registration Number
- IRCT20171029037068N1
- Lead Sponsor
- Ferdowsi University of Mashhad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 68
Primary DSM-5 diagnosis of non-suicidal self-injury (NSSI)
No usage of medication
Being at the age of 18-30 years old
Speaking Persian fluently
Ability to participate in all assessment and treatment sessions
Need for immediate medical treatment or the need for concurrent therapeutic interventions that would interfere with the treatment program
Receiving a full course of pharmacotherapy or psychotherapy, within the past 5 years
Having psychiatric disorders and substance abuse (except tobacco users) within twelve months before screening
Current diagnosis of any mental disorder
A history of epilepsy
Significant head injury or other neurological conditions, or brain surgery
A history of adverse reaction to tDCS or having a sensitive scalp
Patient's opposition to collaboration at any time of research
Having serious thoughts about suicide
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method onsuicidal self-injury. Timepoint: At baseline (pre-treatment), at 8th weeks (post-treatment), and after a 12-month post-treatment followup period. Method of measurement: Inventory of statements about self-injury (ISAS), Structured clinical interview for DSM-5 disorders-clinician version.
- Secondary Outcome Measures
Name Time Method